Kewaunee Scientific Co. (NASDAQ:KEQU – Get Free Report) was the recipient of a large growth in short interest in October. As of October 31st, there was short interest totalling 40,100 shares, a growth of 23.8% from the October 15th total of 32,400 shares. Currently, 1.9% of the shares of the stock are short sold. Based on an average trading volume of 22,500 shares, the days-to-cover ratio is presently 1.8 days.
Wall Street Analyst Weigh In
Separately, StockNews.com raised Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Saturday.
View Our Latest Stock Report on KEQU
Institutional Trading of Kewaunee Scientific
Kewaunee Scientific Trading Down 0.5 %
Shares of Kewaunee Scientific stock traded down $0.19 during trading on Friday, reaching $37.90. 6,164 shares of the company were exchanged, compared to its average volume of 13,719. The company has a quick ratio of 2.00, a current ratio of 2.53 and a debt-to-equity ratio of 0.48. Kewaunee Scientific has a twelve month low of $16.51 and a twelve month high of $55.62. The firm has a market capitalization of $108.77 million, a price-to-earnings ratio of 6.08 and a beta of 0.73. The business has a 50-day moving average price of $34.92 and a 200-day moving average price of $41.56.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last released its quarterly earnings data on Wednesday, September 11th. The technology company reported $0.93 EPS for the quarter. Kewaunee Scientific had a net margin of 9.13% and a return on equity of 25.87%. The business had revenue of $48.39 million during the quarter.
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Further Reading
- Five stocks we like better than Kewaunee Scientific
- Pros And Cons Of Monthly Dividend Stocks
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How Investors Can Find the Best Cheap Dividend Stocks
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What Are the FAANG Stocks and Are They Good Investments?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.